Latest Information Update: 28 Oct 1997
At a glance
- Originator NeuroSearch
- Mechanism of Action Calcium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Stroke
Most Recent Events
- 28 Oct 1997 Suspended-Preclinical for Stroke in Denmark (Unknown route)
- 11 Aug 1995 New profile
- 11 Aug 1995 Preclinical development for Stroke in Denmark (Unknown route)